John C. Byrd

3.2k total citations
56 papers, 2.1k citations indexed

About

John C. Byrd is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, John C. Byrd has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 10 papers in Hematology and 10 papers in Cancer Research. Recurrent topics in John C. Byrd's work include RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). John C. Byrd is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). John C. Byrd collaborates with scholars based in United States, Italy and Taiwan. John C. Byrd's co-authors include Michael R. Grever, Guido Marcucci, Robert A. Baiocchi, Samson T. Jacob, Kenneth K. Chan, Saı̈d Sif, Sharmistha Pal, David Lucas, Natarajan Muthusamy and Carlos E. Castro and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

John C. Byrd

55 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Byrd United States	27	1.7k	324	316	271	204	56	2.1k
Tao Fang China	25	1.0k 0.6×	446 1.4×	185 0.6×	457 1.7×	308 1.5×	53	1.8k
David Rodrı́guez Spain	27	1.2k 0.7×	556 1.7×	185 0.6×	571 2.1×	213 1.0×	66	2.8k
Min Lin China	23	1.1k 0.6×	174 0.5×	316 1.0×	244 0.9×	128 0.6×	48	1.8k
Francesca Margheri Italy	28	1.0k 0.6×	592 1.8×	123 0.4×	492 1.8×	303 1.5×	51	1.8k
Jozo Delić France	19	958 0.6×	147 0.5×	137 0.4×	382 1.4×	192 0.9×	33	1.5k
Neil Ashley United Kingdom	21	1.3k 0.8×	297 0.9×	269 0.9×	442 1.6×	393 1.9×	33	2.3k
Raffaella Villa Italy	29	2.1k 1.2×	259 0.8×	260 0.8×	542 2.0×	152 0.7×	65	3.2k
Danilo Marimpietri Italy	30	1.5k 0.9×	459 1.4×	157 0.5×	578 2.1×	412 2.0×	67	2.6k
Michelle J. Henderson Australia	21	1.6k 0.9×	442 1.4×	139 0.4×	1.1k 4.2×	139 0.7×	40	2.5k

Countries citing papers authored by John C. Byrd

Since Specialization

Citations

This map shows the geographic impact of John C. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Byrd more than expected).

Fields of papers citing papers by John C. Byrd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Byrd. The network helps show where John C. Byrd may publish in the future.

Co-authorship network of co-authors of John C. Byrd

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Byrd. A scholar is included among the top collaborators of John C. Byrd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Byrd. John C. Byrd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eisenmann, Eric D., Kevin M. Huang, Daelynn R. Buelow, et al.. (2022). TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers. 15(1). 29–29. 7 indexed citations

Burd, Amy, Richard L. Schilsky, John C. Byrd, et al.. (2019). Challenges and approaches to implementing master/basket trials in oncology. Blood Advances. 3(14). 2237–2243. 9 indexed citations

Papaioannou, Dimitrios, Deedra Nicolet, Hatice Gülçin Özer, et al.. (2019). Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 18(8). 1451–1459. 12 indexed citations

Hu, Eileen, Priscilla Do, Rajeswaran Mani, et al.. (2017). Evaluation of ROR1 Targeted Antibody Drug Conjugates in Acute and Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma. Blood. 130. 3017–3017. 1 indexed citations

Stiff, Andrew, Enrico Caserta, Douglas W. Sborov, et al.. (2016). Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma. Molecular Cancer Therapeutics. 15(5). 830–841. 31 indexed citations

Harshman, Sean W., Alessandro Canella, Kitty Agarwal, et al.. (2016). Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. Journal of Proteomics. 136. 89–98. 72 indexed citations

Mao, Yicheng, Jiang Wang, Yuan Zhao, et al.. (2014). Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 98. 160–165. 4 indexed citations

Shah, Prexy, Payal Mehta, Julie M. Roda, et al.. (2013). Fcγ Receptor-induced Soluble Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Production Inhibits Angiogenesis and Enhances Efficacy of Anti-tumor Antibodies. Journal of Biological Chemistry. 288(37). 26800–26809. 11 indexed citations

Alachkar, Houda, Ramasamy Santhanam, Jason G. Harb, et al.. (2013). Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. Journal of Hematology & Oncology. 6(1). 21–21. 47 indexed citations

10.

Baer, Constance, Rainer Claus, Lukas P. Frenzel, et al.. (2012). Extensive Promoter DNA Hypermethylation and Hypomethylation Is Associated with Aberrant MicroRNA Expression in Chronic Lymphocytic Leukemia. Cancer Research. 72(15). 3775–3785. 109 indexed citations

11.

Huang, Po-Hsien, Aaron M. Sargeant, Samuel K. Kulp, et al.. (2010). Histone Deacetylase Inhibitors Stimulate Histone H3 Lysine 4 Methylation in Part Via Transcriptional Repression of Histone H3 Lysine 4 Demethylases. Molecular Pharmacology. 79(1). 197–206. 96 indexed citations

12.

Biswas, Sabyasachi, Xiaobin Zhao, Andrew P. Mone, et al.. (2010). Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro. Leukemia Research. 34(7). 925–931. 22 indexed citations

13.

Yang, Xiaoyan, Xinfeng Zhao, Mitch A. Phelps, et al.. (2008). A novel liposomal formulation of flavopiridol. International Journal of Pharmaceutics. 365(1-2). 170–174. 38 indexed citations

14.

Raval, Aparna, et al.. (2006). CpG Island Methylation and Expression of the Secreted Frizzled-Related Protein Gene Family in Chronic Lymphocytic Leukemia. Cancer Research. 66(2). 653–658. 100 indexed citations

15.

Liu, Zhongfa, Guido Marcucci, John C. Byrd, et al.. (2006). Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5‐aza‐2′‐deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification method. Rapid Communications in Mass Spectrometry. 20(7). 1117–1126. 64 indexed citations

16.

Xiao, Jim, John C. Byrd, Guido Marcucci, Michael R. Grever, & Kenneth K. Chan. (2003). Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood. Rapid Communications in Mass Spectrometry. 17(8). 757–766. 32 indexed citations

17.

Mone, Andrew P., J. Yun Tso, D. Lucas, et al.. (2003). Mitochondria control of cell death induced by anti-HLA-DR antibodies. Leukemia. 17(7). 1357–1365. 27 indexed citations

18.

Waselenko, Jamie K., Charlotte Shinn, C. R. Willis, et al.. (2001). Carboxyamido-Triazole (CAI)-a Novel “static” Signal Transduction Inhibitor Induces Apoptosis in Human B-Cell Chronic Lymphocytic Leukemia Cells. Leukemia & lymphoma. 42(5). 1049–1053. 7 indexed citations

19.

Goodwin, Thomas E., C J Boylan, William L. Current, et al.. (2000). Enhanced Pneumocystis carinii activity of new primaquine analogues. Bioorganic & Medicinal Chemistry Letters. 10(19). 2205–2208. 4 indexed citations

20.

Byrd, John C. & Oscar Touster. (1981). Isolation and partial characterization of the oligosaccharide moieties of rat preputial β-glucuronidase. Biochimica et Biophysica Acta (BBA) - General Subjects. 677(1). 69–78. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact